


363 F.3d 1247
United States Court of Appeals,
Federal Circuit.
CHIRON CORPORATION, Plaintiff-Appellant,
v.
GENENTECH, INC., Defendant-Cross Appellant.
Nos. 03-1158, 03-1159.
|
DECIDED: March 30, 2004.
|
Rehearing and Rehearing En Banc Denied June 8, 2004.
Synopsis
Background: Owner of patent for monoclonal antibodies capable of binding to specific human breast cancer antigen sued competitor for infringement. The United States District Court for the Eastern District of California, William B. Shubb, J., entered judgment on jury verdict that patent was invalid as anticipated, and owner appealed.
 
The Court of Appeals, Rader, Circuit Judge, held that patent, which could not claim priority dates of prior applications, was invalid as anticipated.
 
Affirmed.
 
Bryson, Circuit Judge, concurred and filed opinion.
 
See also 268 F.Supp.2d 1148.
 
